Literature DB >> 12149415

Complement's participation in acquired immunity.

Claus Henrik Nielsen1, Robert Graham Quinton Leslie.   

Abstract

The preliminary evidence for the involvement of complement in promoting primary humoral responses dates back over a quarter of a century. However, it is only in the course of the past decade or so that the detailed mechanisms underlying complement's influence have been characterized in depth. It is now clear that complement serves as a regulator of several B cell functions, including specific antibody production, antigen uptake, processing and presentation, and shaping of the B cell repertoire. Of key importance, in this respect, is the role played by the B cell-signaling triad consisting of the B cell receptor for antigen (BCR), a complex composed of the iC3b/C3d fragment-binding complement type 2 receptor (CR2, CD21) and its signaling element CD19 and the IgG-binding receptor FcgammaRIIb (CD32). The positive or negative outcome of signaling through this triad is determined by the context in which antigen is seen, be it alone or in association with natural or induced antibodies and/or C3-complement fragments. The aim of this review is to describe the present status of our understanding of complement's participation in acquired immunity and the regulation of autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149415

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Serum levels of soluble CD21 in patients with systemic sclerosis.

Authors:  Manabu Tomita; Takafumi Kadono; Norihito Yazawa; Tomohiko Kawashima; Zenshiro Tamaki; Ryuichi Ashida; Hanako Ohmatsu; Yoshihide Asano; Makoto Sugaya; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki; Shinichi Sato
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

2.  Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression.

Authors:  I S El-Amouri; M Bani-Ahmad; Y Tang-Feldman; F Lin; C Ko; C Pomeroy; O R Oakley
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

3.  Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

Authors:  Bing Ren; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.

Authors:  Huiying Fan; Tiezhu Tong; Huanchun Chen; Aizhen Guo
Journal:  Virus Genes       Date:  2007-05-12       Impact factor: 2.332

5.  Identification and molecular characterization of a complement C3 molecule in a lophotrochozoan, the Hawaiian bobtail squid Euprymna scolopes.

Authors:  Maria G Castillo; Michael S Goodson; Margaret McFall-Ngai
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

6.  The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.

Authors:  Peter van Lent; Karin C Nabbe; Peter Boross; Arjen B Blom; Johannes Roth; Astrid Holthuysen; Annet Sloetjes; Sjef Verbeek; Wim van den Berg
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 7.  Regulation of humoral immunity by complement.

Authors:  Michael C Carroll; David E Isenman
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

8.  Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.

Authors:  Julia D Burman; Elisa Leung; Karen L Atkins; Maghnus N O'Seaghdha; Lea Lango; Pau Bernadó; Stefan Bagby; Dmitri I Svergun; Timothy J Foster; David E Isenman; Jean M H van den Elsen
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

9.  Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.

Authors:  Lingshu Wang; J Oriol Sunyer; Leonard J Bello
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration.

Authors:  Robert J Ross; Min Zhou; Defen Shen; Robert N Fariss; Xiaoyan Ding; Christine M Bojanowski; Jingsheng Tuo; Chi-Chao Chan
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.